Naoki Manda

418 total citations
22 papers, 262 citations indexed

About

Naoki Manda is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Naoki Manda has authored 22 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Naoki Manda's work include Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (8 papers). Naoki Manda is often cited by papers focused on Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (8 papers). Naoki Manda collaborates with scholars based in Japan and United States. Naoki Manda's co-authors include Tatsuya Atsumi, Yoshio Kurihara, Shin Aoki, Hideaki Miyoshi, Hiroshi Nomoto, Akinobu Nakamura, Tomoo Furumoto, Kyu Yong Cho, Hiroyuki Tsutsui and Koji Oba and has published in prestigious journals such as PLoS ONE, Clinica Chimica Acta and Diabetes Obesity and Metabolism.

In The Last Decade

Naoki Manda

22 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Manda Japan 10 204 99 47 44 29 22 262
Mamiko Tsugawa Japan 11 215 1.1× 77 0.8× 69 1.5× 56 1.3× 17 0.6× 21 324
Hajime Kihara Japan 5 133 0.7× 57 0.6× 38 0.8× 88 2.0× 26 0.9× 11 201
Surya Panicker Rajeev United Kingdom 7 232 1.1× 108 1.1× 107 2.3× 29 0.7× 54 1.9× 14 285
Xiaoxuan Ma China 3 212 1.0× 104 1.1× 103 2.2× 62 1.4× 44 1.5× 5 305
Samantha Ho United States 4 197 1.0× 150 1.5× 130 2.8× 29 0.7× 17 0.6× 6 285
Xue‐Nan Sun China 9 93 0.5× 97 1.0× 71 1.5× 44 1.0× 31 1.1× 14 251
Lingli Zhou China 7 186 0.9× 90 0.9× 78 1.7× 23 0.5× 39 1.3× 17 251
Aditya Goud United States 9 169 0.8× 110 1.1× 109 2.3× 80 1.8× 42 1.4× 24 332
Miriam Kozárová Slovakia 9 179 0.9× 120 1.2× 156 3.3× 33 0.8× 15 0.5× 25 274
Elisa P. Jensen Denmark 8 258 1.3× 89 0.9× 159 3.4× 26 0.6× 42 1.4× 10 322

Countries citing papers authored by Naoki Manda

Since Specialization
Citations

This map shows the geographic impact of Naoki Manda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Manda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Manda more than expected).

Fields of papers citing papers by Naoki Manda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Manda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Manda. The network helps show where Naoki Manda may publish in the future.

Co-authorship network of co-authors of Naoki Manda

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Manda. A scholar is included among the top collaborators of Naoki Manda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Manda. Naoki Manda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iijima, Y., Masafumi Nakayama, Takashi Miwa, et al.. (2023). Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes. Internal Medicine. 62(5). 681–688. 1 indexed citations
3.
Taneda, Shinji, Isao Yokota, Kazufumi Okada, et al.. (2022). The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67). Journal of Diabetes Investigation. 13(11). 1834–1841. 5 indexed citations
4.
Taneda, Shinji, et al.. (2021). Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes. JMA Journal. 4(2). 135–140. 4 indexed citations
5.
6.
Nakamura, Akinobu, Kohei Yamamoto, Hiroshi Nomoto, et al.. (2018). Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial. Journal of Diabetes Investigation. 10(3). 699–705. 29 indexed citations
7.
Takahashi, Kiyohiko, Kyu Yong Cho, Akinobu Nakamura, et al.. (2018). Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 10(2). 429–438. 7 indexed citations
8.
Omori, Kazuno, Hiroshi Nomoto, Akinobu Nakamura, et al.. (2018). Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea. Journal of Diabetes Investigation. 10(2). 367–374. 15 indexed citations
9.
10.
Kikuchi, M, Naoki Hirokawa, Hidetaka Nakayama, et al.. (2017). Ultrasonography Improves Glycemic Control by Detecting Insulin-Derived Localized Amyloidosis. Ultrasound in Medicine & Biology. 43(10). 2284–2294. 9 indexed citations
11.
Miyoshi, Hideaki, Tomoo Furumoto, Kota Ono, et al.. (2017). The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3). Cardiovascular Diabetology. 16(1). 44–45. 27 indexed citations
12.
Nomoto, Hiroshi, Hideaki Miyoshi, Akinobu Nakamura, et al.. (2017). Do DPP-4 inhibitors improve endothelial cell function?. 1(1). 1 indexed citations
13.
Taneda, Shinji, Takaya Fukumoto, M Kikuchi, et al.. (2017). Localized Subcutaneous Insulin-Derived Amyloidosis Excised after Evaluation Using Ultrasonography in a Patient with Type 2 Diabetes Mellitus. Case Reports in Endocrinology. 2017. 1–3. 8 indexed citations
14.
Nomoto, Hiroshi, Hideaki Miyoshi, Akinobu Nakamura, et al.. (2017). Impact of incretin-related agents on endothelial cell function. Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University). 2(1). 0–0. 2 indexed citations
15.
Nomoto, Hiroshi, Hideaki Miyoshi, Tomoo Furumoto, et al.. (2016). A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1). PLoS ONE. 11(10). e0164255–e0164255. 38 indexed citations
16.
17.
Yoshioka, Narihito, Naoki Manda, Hiromichi Kijima, et al.. (2009). Step-up therapy with biphasic insulin aspart-70/30—Sapporo 1-2-3 study. Diabetes Research and Clinical Practice. 85(1). 47–52. 14 indexed citations
18.
Nakayama, Hidetaka, Shinji Taneda, Naoki Manda, et al.. (1986). Radioimmunoassay for nonenzymatically glycated protein in human serum. Clinica Chimica Acta. 158(3). 293–299. 6 indexed citations
19.
Nakayama, Hidetaka, Naoki Manda, Shin Aoki, et al.. (1982). Studies on the Determination of Glucosylated Albumin Using Affinity Chromatography. 25(9). 963–968. 1 indexed citations
20.
Nakayama, Hidetaka, Shin Aoki, Naoki Manda, et al.. (1982). Diabetes Mellitus During the Course of Infectious Mononucleosis. 25(5). 625–631. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamiko Tsugawa Breakdown of academic impact, for papers by Hajime Kihara Breakdown of academic impact, for papers by Surya Panicker Rajeev Breakdown of academic impact, for papers by Xiaoxuan Ma Breakdown of academic impact, for papers by Samantha Ho Breakdown of academic impact, for papers by Xue‐Nan Sun Breakdown of academic impact, for papers by Lingli Zhou Breakdown of academic impact, for papers by Aditya Goud Breakdown of academic impact, for papers by Miriam Kozárová Breakdown of academic impact, for papers by Elisa P. Jensen
Rankless by CCL
2026